ES2115047T3 - Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente. - Google Patents

Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente.

Info

Publication number
ES2115047T3
ES2115047T3 ES93900432T ES93900432T ES2115047T3 ES 2115047 T3 ES2115047 T3 ES 2115047T3 ES 93900432 T ES93900432 T ES 93900432T ES 93900432 T ES93900432 T ES 93900432T ES 2115047 T3 ES2115047 T3 ES 2115047T3
Authority
ES
Spain
Prior art keywords
agent
serum
food
water
indicated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900432T
Other languages
English (en)
Inventor
Yukihiro Takada
Naomichi Kobayashi
Masatoshi Yahiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03356754A external-priority patent/JP3092874B2/ja
Priority claimed from JP14217092A external-priority patent/JP3604159B2/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ES2115047T3 publication Critical patent/ES2115047T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/80Geriatric
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/807Poultry or ruminant feed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN FACTOR FAVORECEDOR DEL CRECIMIENTO DE OSTEOBLASTOS Y DE REFUERZO DE LOS HUESOS, COMPRENDE UN PRECIPITADO PREPARADO AJUSTANTO EL PH DEL SUERO O DE UNA SOLUCION ACUOSA QUE CONTIENE DE 2 A 6 PROTEINAS DEL SUERO, Y LA CONCENTRACION DE ETANOL AL 10 % O MAS; O UN COMPONENTE SOLUBLE EN AGUA PREPARADO DISOLVIENDO EL PRECIPITADO EN AGUA Y DE MANERA QUE TENGA UN PESO MOLECULAR DE 5,000 PESO MOLECULAR DE 5,000 4 A 9 Y SE OBTIENE DE UN CONCENTRADO FORMADO DE UN SUERO CALENTADO O UNA SOLUCION ACUOSA DE PROTEINAS DE SUERO, UN PRECIPITADO FORMADO TRATANDO EL MISMO CON CLORURO SODICO O UNA IMPREGNACION FORMADA POR ULTRAFILTRACION DEL MISMO. LA COMIDA, MEDICINAS Y ALIMENTOS QUE CONTIENEN EL FACTOR ARRIBA INDICADO SON UTILES PARA PREVENIR Y TRATAR OSTEOPATIAS.
ES93900432T 1991-12-26 1992-12-25 Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente. Expired - Lifetime ES2115047T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP03356754A JP3092874B2 (ja) 1991-12-26 1991-12-26 乳清由来の骨芽細胞増殖・骨強化画分及び該画分を含有する骨強化食品、飼料、薬品類
JP14217092A JP3604159B2 (ja) 1992-05-07 1992-05-07 乳清由来の骨芽細胞増殖促進及び骨強化因子ならびに該因子を含有せしめた骨強化食品、医薬および飼料

Publications (1)

Publication Number Publication Date
ES2115047T3 true ES2115047T3 (es) 1998-06-16

Family

ID=26474258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900432T Expired - Lifetime ES2115047T3 (es) 1991-12-26 1992-12-25 Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente.

Country Status (9)

Country Link
US (1) US5654019A (es)
EP (1) EP0573668B1 (es)
AT (1) ATE163858T1 (es)
DE (1) DE69224741T2 (es)
DK (1) DK0573668T3 (es)
ES (1) ES2115047T3 (es)
GR (1) GR3026572T3 (es)
NZ (1) NZ246211A (es)
WO (1) WO1993012807A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3112637B2 (ja) * 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP3073439B2 (ja) * 1996-02-08 2000-08-07 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
JP3018313B2 (ja) * 1996-02-23 2000-03-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
NZ511028A (en) * 1998-10-08 2003-04-29 Bioflash Inc Process for the isolation of milk proteins
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
DE102006036285A1 (de) * 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
AU2008320272B2 (en) * 2007-11-01 2014-01-23 Megmilk Snow Brand Co., Ltd. Food material for inhibiting bone resorption
KR101705905B1 (ko) * 2007-11-01 2017-02-10 유키지루시 메그밀크 가부시키가이샤 골 강화용 식품 소재
FR2988566B1 (fr) * 2012-03-28 2014-08-08 Yoplait France Compositions alimentaires pour stimuler la formation de tissu osseux
ITRM20120368A1 (it) * 2012-07-30 2014-01-31 Ambiotec Sas Composizione in grado di agire sul regolatore del muscolo myod e sulla proliferazione degli osteoblasti

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143174A (en) * 1975-07-24 1979-03-06 Beatrice Foods Co. Food composition containing whey colloidal precipitate
US4089987A (en) * 1976-09-23 1978-05-16 Stauffer Chemical Company Whipping composition of modified whey protein and additives
GB8723094D0 (en) * 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
JPH01126062A (ja) * 1987-11-11 1989-05-18 Ricoh Co Ltd フルカラー読取り装置の色補正装置
DE3743440A1 (de) * 1987-12-21 1989-06-29 Gauri Kailash Kumar Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch
EP0349048A3 (en) * 1988-06-27 1990-07-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth factors derived from regenerating bone marrow
JPH0211599A (ja) * 1988-06-30 1990-01-16 Kaken Pharmaceut Co Ltd 骨芽細胞増殖因子
JP2605835B2 (ja) * 1988-10-18 1997-04-30 味の素株式会社 骨多孔症治療剤
JPH02111797A (ja) * 1988-10-20 1990-04-24 Kaken Pharmaceut Co Ltd 骨芽細胞増殖因子
JPH02218697A (ja) * 1989-02-21 1990-08-31 Suntory Ltd 骨形成活性を有する蛋白質
EP0384731B1 (en) * 1989-02-23 1996-12-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
JP2802436B2 (ja) * 1989-05-19 1998-09-24 雪印乳業株式会社 骨疾患治療・予防剤
JPH03151877A (ja) * 1989-06-02 1991-06-28 Chiron Corp 骨カルシウム沈着因子
JP3160862B2 (ja) * 1990-11-15 2001-04-25 雪印乳業株式会社 骨強化食品、飼料及び医薬

Also Published As

Publication number Publication date
DE69224741T2 (de) 1998-07-02
GR3026572T3 (en) 1998-07-31
NZ246211A (en) 1994-12-22
ATE163858T1 (de) 1998-03-15
US5654019A (en) 1997-08-05
EP0573668A1 (en) 1993-12-15
WO1993012807A1 (en) 1993-07-08
DK0573668T3 (da) 1998-04-27
EP0573668A4 (en) 1995-11-02
EP0573668B1 (en) 1998-03-11
DE69224741D1 (de) 1998-04-16

Similar Documents

Publication Publication Date Title
ES2115047T3 (es) Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente.
US4931441A (en) Stabilized aqueous leucovorin calcium compositions
Glimcher et al. The molecular structure of the protein matrix of bovine dental enamel
NAGELSCHMIDT et al. Effect of fibronectin therapy and fibronectin deficiency on wound healing: a study in rats
ATE113636T1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
KR970706830A (ko) 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2'-dithio-bis (ethanesulfonate) (dimesna)
DK179286D0 (da) Insulinpraeparat
ES2033429T3 (es) Un metodo de preparacion de una composicion farmaceutica.
DE68904121D1 (de) Ibuprofen-cyclodextrin-einschlusskomplexe enthaltende pharmazeutische zubereitungen.
JPS58192818A (ja) インシュリン製剤
UA42028C2 (uk) ПРЕПАРАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ У ВИГЛЯДІ СТАБІЛЬНОГО ВОДНОГО РОЗЧИНУ
JPH04505119A (ja) ヒスチジン緩衝の腹膜透析溶液
KR940703689A (ko) 성장호르몬과 아스파라진으로 이루어지는 안정화된 약학제제(a stabil-ized pharmaceutical formulation comprising growth gormone and asparagine)
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
ES2037136T3 (es) Procedimiento para la preparacion de una solucion con elevada actividad volumetrica de una proteina con actividad de activador de plasminogeno de tejidos (t-pa).
IT1306644B1 (it) Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
ES2028913T3 (es) Procedimiento para la fabricacion de una fraccion que contiene el factor viii (ahf).
KR880007088A (ko) 조직단백질 pp4를 함유하는 약제, pp4의 제조방법, 이의 저온살균법 및 용도
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
KR910005886A (ko) 안정화 백혈구 인터페론
ES2144734T3 (es) Procedimiento para la obtencion de concentrados acuosos de tensioactivos.
DE69508890D1 (de) Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen
FI98891B (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
DK15088D0 (da) Antibakterielt lyofiliseret praeparat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 573668

Country of ref document: ES